• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Smiths Medical partners with Ivenix on infusion management suite

May 4, 2021 By Sean Whooley

smiths-medical IvenixSmiths Medical announced today that it partnered with Ivenix on infusion management.

Minneapolis-based Smiths Medical will invest an unspecified amount in the long-term partnership to “revolutionize” infusion management and improve patient safety while meeting the needs of healthcare providers, according to a news release.

Boston-based Ivenix develops what it touts as “the first and only large-volume infusion pump from the ground up” designed to meet the latest FDA guidelines addressing recurring safety issues with such pumps.

Ivenix’s infusion system consists of the large-volume pump with administration sets, infusion management tools and analytics, too. The FDA granted the system 510(k) clearance in June 2019 and the company says the platform is designed t to reduce infusion-related errors and drive down the cost of ownership.

Smiths Medical said its complementary portfolio of infusion systems, including CADD-Solis and Medfusion, include syringe and ambulatory pumps designed for adult and neonatal critical care, operating rooms and pain management in hospital and home settings.

The company said the addition of the Ivenix infusion system to its U.S. product portfolio will accelerate its offering into the large-volume infusion device segment, a market estimated to top $2 billion. Smiths plans to launch the Ivenix system as part of its portfolio this coming summer.

“The long-term partnership between Smiths Medical and Ivenix will ensure that we are bringing the next generation of infusion management solutions to hospitals across the U.S. and fulfills our commitment to helping connect patients to life-saving therapies and insights to providers,” Smiths Medical CEO JehanZeb Noor said in the release. “Our investment in Ivenix will help spur the research and development needed to continue building on this critical resource and provide holistic solutions for hospitals and health systems.”

“This partnership allows us to accelerate the commercial reach of our infusion platform, and together provide a portfolio of leading-edge infusion solutions to deliver the highest standard of safe and integrated infusion care,” added Ivenix CEO Jorgen B. Hansen.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: Ivenix, Smiths Medical

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS